What category does this event fall under?

Business — classified as share buyback.

What is the sentiment of coverage?

Aggregate sentiment score: 10 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Is this event still developing?

This event is archived — the story has concluded and this page is a final snapshot.

Business share buyback

Coface Share Buyback Disclosures

Q: When did this event occur?

First reported Feb 25, 2025; last updated Apr 07, 2025.

Q: What is the market impact?

General. The share buyback program by Prothrombin complex concentrate is generally viewed positively by the market, as it can reduce the number of outstanding shares and potentially increase earnings per share, supporting the stock price of Prothrombin complex concentrate.

Analysis based on 7 articles · First reported Feb 25, 2025 · Last updated Apr 07, 2025

Sentiment

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

The share buyback program by Prothrombin complex concentrate is generally viewed positively by the market, as it can reduce the number of outstanding shares and potentially increase earnings per share, supporting the stock price of Prothrombin complex concentrate. The disclosures provide transparency to market participants regarding the company's ongoing buyback activities on Euronext Paris.

Financial services

Event Summary

Prothrombin complex concentrate has been disclosing its trading in own shares as part of its 2024-2025 Share Buyback Program. These disclosures cover various periods in February, March, and April 2025, detailing transactions made on Euronext Paris. For instance, on February 21, 2025, Prothrombin complex concentrate bought back 10,000 shares at a weighted average price of 16.0826 euros, totaling 160,826.70 euros, for its Long Term Incentive Plan (LTIP). The company regularly publishes the main features of its buyback program on its website and in its Universal Registration Document, adhering to Regulation (EU) No 596/2014 on market abuse.

Entities Involved

exch

Euronext Paris

Euronext Paris is the exchange where Prothrombin complex concentrate shares are traded and where the buyback transactions are executed.

Importance 10.0 Sentiment 0.0

ERGEN INTELLIGENCE

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard